New Turkish Pharma Plant To Supply Azerbaijan With Crucial Medicines


(MENAFN- Trend News Agency) BAKU, Azerbaijan, December 7. Turkish Gen Pharma Caucasus Manufacturing Operations LLC pharma plant in Azerbaijan's Pirallahi Industrial Park will supply the country with crucial medicines, the head of the company Abidin Gulmus said, Trend reports.

"Today is a historic day. The project will contribute to Azerbaijan's healthcare. This is not only a pharmaceutical plant; it will provide employment opportunities for graduates from pharmaceutical faculties and serve as a platform for realizing their projects," he noted.

Gulmus also said that the project consists of two phases.

“We plan to complete the first phase by the end of 2025. The second should begin in 2026,” he added.

Gen Pharma Caucasus Manufacturing Operations LLC received the status of a resident of Azerbaijan's Pirallahi Industrial Park, thus bringing the number of the industrial park residents to six.

The company will produce high quality medicines in 42 names and various forms (pills, capsules, gelatin capsules, powder suspension, syrup, etc.) and dosage on the territory of 7.8 hectares of the industrial complex.

The enterprise with an investment cost of 59.3 million manat ($34.88 million) will employ 165 people. The enterprise with annual production capacity of 50 million packages will be built within the framework of trilateral cooperation between Azerbaijan Investment Company OJSC, "Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret A.S." and "Sia Pharmaceuticals" LLCs of Türkiye.

Stay up-to-date with more news at Trend News Agency's WhatsApp channel

MENAFN07122023000187011040ID1107552690


Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.